Nichols named LLS chief medical officer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Gwen Nichols was named chief medical officer of the Leukemia & Lymphoma Society.

A physician and scientific researcher, Nichols has advanced cures for cancers through a unique combination of clinical, academic and pharmaceutical experience. AS CSO, she will oversee LLS’s scientific research portfolio, patient access services and policy and advocacy initiatives.

Most recently, Nichols was oncology site head of the Roche Translational Clinical Research Center, where she worked to develop new cancer therapies, translating them from the laboratory to clinical trials. Prior to joining Roche in 2007, Nichols was at Columbia University for more than ten years, where she served as the director of the Hematologic Malignancies Program.

Table of Contents

YOU MAY BE INTERESTED IN

Candace S. Johnson leads America’s oldest cancer research center and Jonathan W. Friedberg leads the newest NCI-designated center. Their catchment areas are contiguous, their faculty and staff members collaborate often, and together their institutions embody the culture of NCI-designated cancer centers. 

In the first meeting of the National Cancer Advisory Board since the inauguration of President Donald Trump, NCI Principal Deputy Director Douglas R. Lowy addressed many of the burning questions the oncology field has for the institute. On indirect costs: NCI will continue to use previously negotiated and approved indirect cost rates, with the exception...

The Cancer Letter staff were finalists for nine 2025 Dateline Awards from the Washington, D.C. Chapter of the Society of Professional Journalists—seven for journalism; two for design—and won first place for four. The Cancer Letter’s entries recognized by SPJ include investigative journalism, series, breaking news, features, photojournalism, commentary, illustration, and front page design. This is...

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login